HCA Healthcare, Inc. $HCA Shares Acquired by Dixon Mitchell Investment Counsel Inc.

Dixon Mitchell Investment Counsel Inc. lifted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCAFree Report) by 2.3% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 75,803 shares of the company’s stock after acquiring an additional 1,699 shares during the period. HCA Healthcare accounts for approximately 1.2% of Dixon Mitchell Investment Counsel Inc.’s investment portfolio, making the stock its 27th biggest holding. Dixon Mitchell Investment Counsel Inc.’s holdings in HCA Healthcare were worth $35,431,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in HCA. Palisade Asset Management LLC acquired a new position in HCA Healthcare in the third quarter valued at $26,000. Holos Integrated Wealth LLC acquired a new position in HCA Healthcare in the fourth quarter valued at $29,000. Ares Financial Consulting LLC acquired a new position in HCA Healthcare in the fourth quarter valued at $31,000. JPL Wealth Management LLC acquired a new position in HCA Healthcare in the third quarter valued at $33,000. Finally, Aventura Private Wealth LLC acquired a new stake in shares of HCA Healthcare during the fourth quarter worth about $34,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on HCA shares. Barclays decreased their target price on shares of HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating for the company in a research note on Monday, April 27th. KeyCorp cut their target price on shares of HCA Healthcare from $550.00 to $510.00 and set an “overweight” rating on the stock in a research note on Monday, April 27th. Wall Street Zen downgraded shares of HCA Healthcare from a “buy” rating to a “hold” rating in a research note on Saturday, May 2nd. Mizuho lifted their price target on shares of HCA Healthcare from $540.00 to $585.00 and gave the stock an “outperform” rating in a research note on Wednesday, February 25th. Finally, TD Cowen dropped their target price on shares of HCA Healthcare from $561.00 to $500.00 and set a “buy” rating for the company in a research report on Monday, April 27th. Fifteen analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, HCA Healthcare has an average rating of “Moderate Buy” and a consensus price target of $506.14.

Get Our Latest Research Report on HCA

HCA Healthcare Stock Performance

NYSE HCA opened at $387.25 on Friday. HCA Healthcare, Inc. has a one year low of $330.00 and a one year high of $556.52. The company has a 50-day simple moving average of $429.60 and a 200-day simple moving average of $473.48. The firm has a market capitalization of $85.91 billion, a PE ratio of 13.32, a price-to-earnings-growth ratio of 1.23 and a beta of 1.12.

HCA Healthcare (NYSE:HCAGet Free Report) last posted its quarterly earnings results on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing the consensus estimate of $7.19 by ($0.04). The business had revenue of $19.11 billion during the quarter, compared to analyst estimates of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The company’s quarterly revenue was up 4.3% on a year-over-year basis. During the same period last year, the firm posted $6.45 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Equities analysts forecast that HCA Healthcare, Inc. will post 30.07 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be paid a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend is Tuesday, June 16th. HCA Healthcare’s payout ratio is presently 10.73%.

About HCA Healthcare

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Further Reading

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.